These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33138058)

  • 1. Development of Self-Associating SN-38-Conjugated Poly(ethylene oxide)-Poly(ester) Micelles for Colorectal Cancer Therapy.
    Sadat SMA; Vakili MR; Paiva IM; Weinfeld M; Lavasanifar A
    Pharmaceutics; 2020 Oct; 12(11):. PubMed ID: 33138058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic Nanomedicine Delivering Topoisomerase I Toxin (SN-38) and Inhibitors of Polynucleotide Kinase 3'-Phosphatase (PNKP) for Enhanced Treatment of Colorectal Cancer.
    Sadat SMA; Vakili MR; Abd-El Hafeez SI; Paladino M; Hall DG; Weinfeld M; Lavasanifar A
    Mol Pharm; 2024 Jul; 21(7):3240-3255. PubMed ID: 38785196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-associating poly(ethylene oxide)-b-poly(alpha-cholesteryl carboxylate-epsilon-caprolactone) block copolymer for the solubilization of STAT-3 inhibitor cucurbitacin I.
    Mahmud A; Patel S; Molavi O; Choi P; Samuel J; Lavasanifar A
    Biomacromolecules; 2009 Mar; 10(3):471-8. PubMed ID: 19175305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of novel polymeric micellar drug conjugates and nano-containers with hydrolyzable core structure for doxorubicin delivery.
    Mahmud A; Xiong XB; Lavasanifar A
    Eur J Pharm Biopharm; 2008 Aug; 69(3):923-34. PubMed ID: 18430550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymeric micelles based on poly(ethylene oxide) and α-carbon substituted poly(ɛ-caprolactone): An in vitro study on the effect of core forming block on polymeric micellar stability, biocompatibility, and immunogenicity.
    Garg SM; Vakili MR; Lavasanifar A
    Colloids Surf B Biointerfaces; 2015 Aug; 132():161-70. PubMed ID: 26037706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional polymeric micelles for enhanced intracellular delivery of doxorubicin to metastatic cancer cells.
    Xiong XB; Mahmud A; Uludağ H; Lavasanifar A
    Pharm Res; 2008 Nov; 25(11):2555-66. PubMed ID: 18636321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the thermo- and pH-responsive assembly of triblock copolymers based on poly(ethylene glycol) and functionalized poly(ε-caprolactone).
    Safaei Nikouei N; Lavasanifar A
    Acta Biomater; 2011 Oct; 7(10):3708-18. PubMed ID: 21672641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the self assembly of methoxy poly(ethylene oxide)-block-poly(α-benzyl carboxylate-ε-caprolactone) for the solubilization and in vivo delivery of valspodar.
    Binkhathlan Z; Elhasi S; Brocks DR; Lavasanifar A
    Curr Drug Deliv; 2012 Mar; 9(2):164-71. PubMed ID: 22283648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-Associating Poly(ethylene oxide)-block-poly(α-carboxyl-ε-caprolactone) Drug Conjugates for the Delivery of STAT3 Inhibitor JSI-124: Potential Application in Cancer Immunotherapy.
    Garg SM; Vakili MR; Molavi O; Lavasanifar A
    Mol Pharm; 2017 Aug; 14(8):2570-2584. PubMed ID: 28221800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(ethylene glycol)-poly(ε-caprolactone)-based micelles for solubilization and tumor-targeted delivery of silibinin.
    Hassankhani Rad A; Asiaee F; Jafari S; Shayanfar A; Lavasanifar A; Molavi O
    Bioimpacts; 2020; 10(2):87-95. PubMed ID: 32363152
    [No Abstract]   [Full Text] [Related]  

  • 11. Fine tuning micellar core-forming block of poly(ethylene glycol)-block-poly(ε-caprolactone) amphiphilic copolymers based on chemical modification for the solubilization and delivery of doxorubicin.
    Yan J; Ye Z; Chen M; Liu Z; Xiao Y; Zhang Y; Zhou Y; Tan W; Lang M
    Biomacromolecules; 2011 Jul; 12(7):2562-72. PubMed ID: 21598958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Traceable Rituximab-Modified PEO-Polyester Micelles by Postinsertion of PEG-phospholipids for Targeting of B-cell Lymphoma.
    Saqr A; Vakili MR; Huang YH; Lai R; Lavasanifar A
    ACS Omega; 2019 Nov; 4(20):18867-18879. PubMed ID: 31737848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of self-assembly conditions on the size of di- and tri-block copolymer micelles: solicitation from response surface methodology.
    Honary S; Lavasanifar A
    Pharm Dev Technol; 2015 Dec; 20(8):957-965. PubMed ID: 25162774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymeric micelles for GSH-triggered delivery of arsenic species to cancer cells.
    Zhang Q; Vakili MR; Li XF; Lavasanifar A; Le XC
    Biomaterials; 2014 Aug; 35(25):7088-100. PubMed ID: 24840615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination Loading of Doxorubicin and Resveratrol in Polymeric Micelles for Increased Loading Efficiency and Efficacy.
    Washington KE; Kularatne RN; Biewer MC; Stefan MC
    ACS Biomater Sci Eng; 2018 Mar; 4(3):997-1004. PubMed ID: 33418782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymeric micelles for the solubilization and delivery of STAT3 inhibitor cucurbitacins in solid tumors.
    Molavi O; Ma Z; Mahmud A; Alshamsan A; Samuel J; Lai R; Kwon GS; Lavasanifar A
    Int J Pharm; 2008 Jan; 347(1-2):118-27. PubMed ID: 17681440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Traceable PEO-poly(ester) micelles for breast cancer targeting: The effect of core structure and targeting peptide on micellar tumor accumulation.
    Garg SM; Paiva IM; Vakili MR; Soudy R; Agopsowicz K; Soleimani AH; Hitt M; Kaur K; Lavasanifar A
    Biomaterials; 2017 Nov; 144():17-29. PubMed ID: 28818703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymeric micelles for pH-responsive delivery of cisplatin.
    Shahin M; Safaei-Nikouei N; Lavasanifar A
    J Drug Target; 2014 Aug; 22(7):629-37. PubMed ID: 24878378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decoration of polymeric micelles with cancer-specific peptide ligands for active targeting of paclitaxel.
    Shahin M; Ahmed S; Kaur K; Lavasanifar A
    Biomaterials; 2011 Aug; 32(22):5123-33. PubMed ID: 21501865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel self-associating poly(ethylene oxide)-b-poly(epsilon-caprolactone) based drug conjugates and nano-containers for paclitaxel delivery.
    Shahin M; Lavasanifar A
    Int J Pharm; 2010 Apr; 389(1-2):213-22. PubMed ID: 20080163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.